NFKB1 and colorectal cancer: Also, the administration of GTE capsules (800 mg EGCG) seems to regulate biomarkers related to colorectal cancer pathogenesis, especially genes associated with selenoproteins, WNT signaling (β-catenin), inflammation (NF-κB), and methylation (DNMT1) [333].